F13A1 and metabolic dysfunction-associated steatotic liver disease: Coagulation factors would be expected to decrease when liver functions are impaired (40), even though in lean NAFLD patients, we only observed reductions in plasma coagulation factor XIII A chain (F13A1) levels.